Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.76 - $3.0 $25,578 - $43,599
-14,533 Reduced 38.75%
22,967 $49,000
Q1 2024

May 13, 2024

BUY
$1.42 - $3.0 $53,250 - $112,500
37,500 New
37,500 $76,000

Others Institutions Holding BIAF

About bioAffinity Technologies, Inc.


  • Ticker BIAF
  • Exchange
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 2,727,580
  • Market Cap $3.35M
  • Description
  • bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...
More about BIAF
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.